Announcements
- Bavarian Nordic lancerer aktietilbagekøbsprogram til afdækning af incitamentsprogrammer
- Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations
- Bavarian Nordic Announces Interim Results for the First Three Months of 2024
- Bavarian Nordic offentliggør delårsregnskab for første kvartal 2024
- Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer
- Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
- Bavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic Reserve
- Bavarian Nordic modtager kontrakt på EUR 65 mio. vedrørende levering af koppevacciner til strategisk lager i EU
- Bavarian Nordic påbegynder løbende registreringsansøgning for chikungunya-vaccine til de amerikanske sundhedsmyndigheder
- Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate
More ▼
Key statistics
On Friday, Bavarian Nordic A/S (BV3A:FRA) closed at 6.95, 28.70% above the 52 week low of 5.40 set on Oct 20, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.90 |
---|---|
High | 6.95 |
Low | 6.90 |
Bid | 6.90 |
Offer | 7.65 |
Previous close | 6.90 |
Average volume | 0.00 |
---|---|
Shares outstanding | 234.30m |
Free float | 234.08m |
P/E (TTM) | 12.37 |
Market cap | 1.83bn USD |
EPS (TTM) | 0.6195 USD |
Data delayed at least 15 minutes, as of May 10 2024 14:29 BST.
More ▼